Waterloo scientists have developed a new way to understand how the universe began, and it could change what we know about the Big Bang and the earliest moments of cosmic history. Their work suggests ...

Learn how to determine the resultant vector by adding, subtracting and multiplying vectors by a scalar. We will also learn ...

This familiar phenomenon has puzzled researchers for centuries, but experiments are finally making sense of its unruly behaviors ...

A new study from the Italian Institute of Technology (IIT), in collaboration with Uppsala University (Sweden) and AstraZeneca, shows how computational chemistry and supercomputers can help scientists ...

The House committee of justice on Monday determined that the two impeachment complaints against President Ferdinand "Bongbong" Marcos, Jr. were sufficient in form. The vote for sufficiency in form for ...

Kevin Stefanski took the Atlanta Falcons head coaching job on Saturday night and he's already started putting together his staff. According to NFL Network insider Mike Garafolo, the Falcons are ...

Add Yahoo as a preferred source to see more of our stories on Google. Dollar General continues to expand its footprint within Somerset County, as a new store opened in November near the Hidden Valley ...

An American Airlines plane is seen at the gates of Terminal D at DFW Airport on Tuesday, Nov. 4, 2025. Smiley N. Pool / Staff Photographer American Airlines is bulking up its domestic schedule from ...

Adding tucatinib to standard first-line maintenance therapy in patients with HER2-positive metastatic breast cancer led to a clinically meaningful delay in disease progression, regardless of the ...

FRANKFORT, Ky. (Dec. 11, 2025) – Kentucky’s maritime transportation and logistics sectors are poised for new growth as Hines Furlong Line (HFL) announced a major expansion of its operations in ...

Epcoritamab addition to R2 significantly improves progression-free survival and overall response rates in relapsed follicular lymphoma. The EPCORE FL-1 trial results show a 79% progression-free ...

Becoming a blockbuster in its third full year on the market put Gilead’s cancer treatment Trodelvy on a course to potentially justify the company’s $21 billion buyout of Immunomedics in 2020. But ...